Medtronic /
Intersect ENT
Medtronic adds Intersect ENT’s sinus implant products
- Terms
- Not stated
- Stage
- Closed
What happened
Medtronic plc completed its acquisition of Intersect ENT, adding the PROPEL and SINUVA sinus implant product lines, technology, intellectual property and facility to its portfolio.
Intersect ENT employees joined Medtronic through the acquisition. Each share of Intersect ENT common stock converted into the right to receive $28.25 in cash.
The source
Everything on this page comes from the source below.
Medtronic adds Intersect ENT’s sinus implant products
This document is the source for the companies, stage and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Published by the source
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly